Evidence map›Paper›PMID 17409249›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states.

John C Earnheart, Claude Schweizer, Florence Crestani, Takuji Iwasato, Shigeyoshi Itohara, Hanns Mohler, Bernhard Lüscher

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 201 citations in OpenAlex.

  1. GABADrug design, development and therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The fate of interneurons, GABABrain pathology (Zurich, Switzerland) · 2023
    Review
  8. In Vivo Antidepressant-Like Effect Assessment of TwoMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Mechanisms of Psychiatric Comorbidities in Epilepsy.Current topics in behavioral neurosciences · 2022
    Article
  14. α2-containing γ-aminobutyric acid type A receptors promote stress resiliency in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  15. GABAIUPHAR/BPS guide to pharmacology CITE · 2021
    Article
  16. Review
  17. Article
  18. Deeper Insights onPlants (Basel, Switzerland) · 2021
    Article
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

John C EarnheartDepartment of Biology and Penn State Neuroscience Institute, Penn State University, University Park, Pennsylvania 16802, USA.
Claude Schweizer
Florence Crestani
Takuji Iwasato
Shigeyoshi Itohara
Hanns Mohler
Bernhard Lüscher
RIKEN Center for Brain Science · JPUniversity of Zurich · CHPennsylvania State University · US

Funding

Mapping the Neural Substrate of AnxietyR01MH060989 · NIMH · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI LUSCHER, BERNHARD · 2001 to 2009
$2.2M
Clustering and Synaptic Targeting of GABA-A ReceptorsR01MH062391 · NIMH · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI LUSCHER, BERNHARD · 2002 to 2006
$1.5M
Protein Trafficking Regulating the Formation of GABAergic SynapsesR56MH062391 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI LUSCHER, BERNHARD · 2008 to 2008
$361k
NIMH NIH HHS MH60989NIMH NIH HHS MH62391NIMH NIH HHS R01 MH060989NIMH NIH HHS R01 MH062391NIMH NIH HHS R56 MH062391
6 · The paper itself

Abstract

Stressful experiences in early life are known risk factors for anxiety and depressive illnesses, and they inhibit hippocampal neurogenesis and the expression of GABA(A) receptors in adulthood. Conversely, deficits in GABAergic neurotransmission and reduced neurogenesis are implicated in the etiology of pathological anxiety and diverse mood disorders. Mice that are heterozygous for the gamma2 subunit of GABA(A) receptors exhibit a modest functional deficit in mainly postsynaptic GABA(A) receptors that is associated with a behavioral, cognitive, and pharmacological phenotype indicative of heightened trait anxiety. Here we used cell type-specific and developmentally controlled inactivation of the gamma2 subunit gene to further analyze the mechanism and brain substrate underlying this phenotype. Heterozygous deletion of the gamma2 subunit induced selectively in immature neurons of the embryonic and adult forebrain resulted in reduced adult hippocampal neurogenesis associated with heightened behavioral inhibition to naturally aversive situations, including stressful situations known to be sensitive to antidepressant drug treatment. Reduced adult hippocampal neurogenesis was associated with normal cell proliferation, indicating a selective vulnerability of postmitotic immature neurons to modest functional deficits in gamma2 subunit-containing GABA(A) receptors. In contrast, a comparable forebrain-specific GABA(A) receptor deficit induced selectively in mature neurons during adolescence lacked neurogenic and behavioral consequences. These results suggest that modestly reduced GABA(A) receptor function in immature neurons of the developing and adult brain can serve as a common molecular substrate for deficits in adult neurogenesis and behavior indicative of anxious and depressive-like mood states.

Indexed as

AnimalsAnxietyCell DifferentiationDepressive DisorderHippocampusMiceMice, KnockoutNeuronsReceptors, GABA-AReceptors, GABA-A

Identifiers

PMID17409249
PMCPMC2441879
OpenAlexW2060890501

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.